{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-24-035033","form_type":"8-K","ticker":"WINT","cik":"0000946486","company_name":"WINDTREE THERAPEUTICS INC /DE/","filed_at":"2024-11-14T23:59:59+00:00","discovered_at":"2026-05-14T18:03:11.456517+00:00","generated_at":"2026-05-30T00:43:32.043183+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Windtree CEO Craig Fraser retires; Jed Latkin appointed President & CEO effective Dec 1, 2024","bullets":["Craig Fraser retires as President and CEO effective Dec 1, 2024, but remains Chairman of the Board.","Jed Latkin, age 50, appointed President and CEO; previously COO and CFO of ProPhase Labs.","Latkin's base salary set at $557,300, with target annual bonus of 50% of base salary.","Latkin eligible for equity award of 2.5% of outstanding shares, subject to shareholder approval.","Employment agreement includes 12-month non-compete and severance benefits for termination without cause or change in control."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-24-035033","json":"https://secwatch.observer/filing/0001437749-24-035033.json","markdown":"https://secwatch.observer/filing/0001437749-24-035033.md","text":"https://secwatch.observer/filing/0001437749-24-035033.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/946486/000143774924035033/0001437749-24-035033-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/946486/000143774924035033/wint20241113_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T00:43:32.043183+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"1e18c486f5","claim":"Craig Fraser retired as President and Chief Executive Officer at WINDTREE THERAPEUTICS INC /DE/.","evidence_excerpt":"Craig Fraser will retire as the Company’s President and Chief Executive Officer, effective as of December 1, 2024","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/946486/000143774924035033/0001437749-24-035033-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"retired"},{"label":"Role","value":"President and Chief Executive Officer"}],"fact_type":"executive_change"},{"claim_id":"bcbc703dc0","claim":"Jed Latkin was appointed as President and Chief Executive Officer at WINDTREE THERAPEUTICS INC /DE/.","evidence_excerpt":"the Company announced the appointment of Jed Latkin, age 50, a current member of the Board, to serve as the Company’s President and Chief Executive Officer, effective as of the Transition Date.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/946486/000143774924035033/0001437749-24-035033-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"President and Chief Executive Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}